TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3883-3889

  Kanaly, Suzanne T ^a   Nashleanas, Michelle ^a   Hondowicz, Brian ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN P55; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HELPER CELL; INFLAMMATION; INFLAMMATORY CELL; LEISHMANIA MAJOR; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHODOCOCCUS EQUI;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; INFLAMMATION; INTRACELLULAR FLUID; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RHODOCOCCUS EQUI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033215169     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
2. Lenardo, M. J. 1996. Fas and the art of lymphocyte maintenance. J. Exp. Med. 183:721.
3. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
4. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
5. Zhou, T., C. K. Edwards, P. Yang, Z. Wang, H. Bluethmann, and J. D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in Ipr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:2661.
6. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
7. Scott, P. 1996. T helper cell development and regulation in experimental cutaneous leishmaniasis. Chem. Immunol. 63:98.
8. Prescott, J. F., and A. M. Hoffman. 1993. Rhodococcus equi. Vet. Clin. North Am. - Equine Pract. 9:375.
9. Hines, S. A., S. T. Kanaly, B. A. Byrne, and G. Palmer. 1997. Immunity to Rhodococcus equi. Vet. Microbiol. 56:177.
10. Kanaly, S. T., S. A. Hines, and G. H. Palmer. 1995. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 63:3037.
11. Vieira. L. Q., M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott. 1996. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157:827.
12. Nashleanas, M., S. Kanaly, and P. Scott. 1998. Control of Leishmania major infection in mice lacking TNF receptors. J Immunol. 160:5506.
13. Pfeffer, K., T. Matsuyama, T. M. Kurdig, A. Wakeham, K. Kishihara, A. Shahinian, K. Weignmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
14. Sacks, D. H., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417.
15. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
16. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39.
17. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100.
18. Milik, A. M., V. A. Buechner-Maxwell, J. Sonstein, S. Kim, G. D. Seitzman, T. F. Seals, and J. L. Curtis. 1997. Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen. J. Clin. Invest. 99:1082.
19. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
20. Boyer, M. H., and C. L. Jaffe. 1984. Increased susceptibility to Leishmania tropica infection in autoimmune MRL/MpJ-lpr mice. J. Parasitol. 70:145.
21. Conceicao-Silva, F., M. Hahne, M. Schroter, J. Louis, and J. Tschoop. 1998. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APo-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28:237.
22. Huang, F. P., D. Xu, E. O. Esfandiari, W. Sands, X. Q. Wei, and F. Y. Liew. 1998. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J. Immunol. 160:4143.
23. Sytwu, H. K., R. S. Liblau, and H. O. McDevitt. 1996. The roles of Fas/Apo-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
24. Singer, G. G., and A. K. Abbas. 1994. The fas antigen in involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
25. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
26. Yap, G. S., T. Scharton-Kersten, H. Charest, and A. Sher. 1998. Decreased resistance to TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1340.
27. Rothe, J., W. Lesslauer. H. Loetscher, Y. Lang, P. Koebel, F. Koentgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993 Mice lacking the tumor necrosis receptor I are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
28. Flynn, J. L., M.M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required for the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
29. Marino, M.W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deticient mice. Proc. Natt. Acad. Sci. USA 94:8093.
30. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170:2097.
31. Kossodo, S., G. E. Grau, J. A. Louis, and I. Muller. 1994. Tumor necrosis factor α (TNF-α) and TNF-β and their receptors in experimental cutaneous leishmaniasis. Infect. Immun. 62:1414.
32. Liew, F. Y., Y. Li. and S. Millott. 1990. Tumour necrosis factor (TNF-α) in leishmaniasis. II. TNF-α-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71:556.
33. Garcia, I., Y. Miyazaki, K. Araki, M. Araki, R. Lucas, G. E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401.
34. Hsu, H., H.-B. Shu, M.-G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor I signal transduction pathways. Cell 84:299.
35. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
36. Liew, F. Y., Y. Li, A. Severn, S. Millot, J. Schmidt, M. Salter, S. Moncada. 1991. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 22:1143.
37. Hodge-Dufour, J., M. W. Marino, M. R. Horton, A. Jungbluth, M. D. Burdick, R. M. Strieter, P. W. Noble, C. A. Hunter, and E. Pure. 1998. Inhibition of interferon γ induced interleukin 12 production: a potential mechanism for the antiinflammatory activities of tumor necrosis factor. Proc. Natl. Acad. Sci. 95:13806.
38. Flesch, I. E. A., J. H. Hess, S. Huang, M. Aguel, J. Rothe, H. Bluethmann, and S. H. E. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181:1615.
39. Becher, B., M. Blain, P. S. Giacomini, and J. P. Antel. 1999. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 162:684.
40. Nordmann, P., J. J. Kerestedjian, and E. Ronco. 1992. Therapy of Rhodococcus equi disseminated infections in nude mice. Antimicrob. Agents Chemother. 36: 1244.